François Meurgey

Senior Training Consultant

François helps pharmaceutical companies to build robust Marketing and Market Access strategies, and to develop their managers to implement successfully strategy and lead cross-functional teams. He has facilitated training workshops in Europe, Asia, the Middle-East and North America.

François has garnered deep expertise in Strategic Marketing and Market Access over a 25-year career in the biopharmaceutical industry. He has been closely involved in the management of three blockbusters (Prozac, Zyrtec and Keppra) and has developed successful go-to-market strategies for top tier Pharma companies as well as small biotechs.

François joined Eli Lilly in 1989 and spent ten years in the company, lastly as Director of Sales and Marketing for Lilly in Belgium (1994-1997) and Director of Global Marketing for Prozac® at Lilly headquarters in the US (1997-1999). François then went to Merck, Sharp & Dohme in the US where he was Senior Director, Asia-Pacific Marketing, before joining Pharmacia where he was Senior Director, US and Global CNS Marketing. He joined UCB in 2003 at the company’s global headquarters in Brussels, first as Vice-President of Global Marketing and in 2005 became Senior Vice-President in charge of UCB’s Center of Excellence, which included Market Research and Marketing Services, New Product Planning and Portfolio Management, Government Affairs, Pricing & Reimbursement, as well as Global Sales Force Effectiveness and Sales & Marketing Training.

François founded in 2007 Oukelos sprl, a consultancy firm specializing in Strategic Pharma Marketing and Market Access. He has completed assignments with a broad range of clients, in the US, Europe and Asia, and teaches at Business Schools across Europe (ESSEC in Paris, ULB in Brussels and SIMI in Copenhagen) and the US (Columbia Business School and Graduate School of Public Health).

François is perfectly bilingual in French and English. He is also conversant in German, Dutch and Italian, and has some basic knowledge of Russian and Spanish.